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Summary box
 ► Antimicrobial resistance (AMR) is a major challenge 
of our time. A key global objective is to reduce an-
tibiotic use, in order to reduce resistance caused by 
antimicrobial pressure. Many interventions aimed 
to lower antibiotic use are based on models of be-
haviour change.
 ► Understanding antibiotic use in low-income and 
middle-income countries requires shifting attention 
to the structural dimensions of AMR and AMU that 
tend to be obscured when following an individual 
behaviour change approach.
 ► Antibiotics function as a ‘quick fix’. They are a quick 
fix for care in fractured health systems; a quick fix 
for productivity at local and global scales, for hu-
mans, animals and crops; a quick fix for hygiene 
in settings of minimised resources; and a quick fix 
for inequality in landscapes scarred by political and 
economic violence.
 ► Recognising many of our AMR solutions as quick 
fixes allows us to raise our line of sight into the lon-
ger term, generating more systemic solutions that 
have greater chance of achieving equitable impact.
AbSTrACT
Antimicrobial resistance (AMR) is a major challenge of 
our time. A key global objective is to reduce antibiotic 
use (ABU), in order to reduce resistance caused by 
antimicrobial pressure. This is often set as a ‘behaviour 
change’ issue, locating intervention efforts in the 
knowledge and attitudes of individual prescribers and 
users of medicines. Such approaches have had limited 
impact and fall short of addressing wider drivers of 
antibiotic use. To address the magnitude of antibiotic 
overuse requires a wider lens to view our relationships 
with these medicines.
This article draws on ethnographic research from East 
Africa to answer the question of what roles antibiotics 
play beyond their immediate curative effects. We carried 
out interviews, participant observation and documentary 
analysis over a decade in northeast Tanzania and eastern 
and central Uganda. Our findings suggest that antibiotics 
have become a ‘quick fix’ in our modern societies. They 
are a quick fix for care in fractured health systems; a quick 
fix for productivity at local and global scales, for humans, 
animals and crops; a quick fix for hygiene in settings of 
minimised resources; and a quick fix for inequality in 
landscapes scarred by political and economic violence. 
Conceptualising antibiotic use as a ‘quick fix’ infrastructure 
shifts attention to the structural dimensions of AMR and 
antimicrobial use (AMU) and raises our line of sight into the 
longer term, generating more systemic solutions that have 
greater chance of achieving equitable impact.
InTroduCTIon
Antimicrobial resistance (AMR) is a major 
challenge of our time. Governments around 
the globe are being encouraged to commit 
resources to tackle this issue. A key global 
objective is to reduce antibiotic use, in order 
to reduce resistance caused by antimicrobial 
pressure.1 2 Set out as a One Health problem, 
interventions are aimed at reducing anti-
microbial use in human health, agriculture 
and in the environment.1 3 Low-income and 
middle-income countries (LMICs) have 
been identified as a specific target for AMR 
and antibiotic use policies due to a range of 
factors that locate them as particularly vulner-
able to the effects of AMR,4 5 as well as the 
perception of them as posing a risk to other 
countries through the connectivity rendered 
so apparent in previous pandemic scares.6 7
How best to reduce antibiotic use remains 
a challenge. To date, attempts to reduce anti-
biotic prescribing and use have had mixed 
effects,8–10 and calls have been made for social 
research to understand why antibiotic use is 
so entrenched.11 There is a growing litera-
ture that explores the reasons for patients’ or 
doctors’ preferences for antibiotic use, such 
as knowledge, attitudes and incentives.12 13 
This paper aims to bring into view the wider 
problems that these medicines have become 
solutions for, foregrounding the structural 
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Figure 1 Antibiotics as a quick fix.
box 1 Antibiotics as a quick fix for care and productivity
After driving off-road for an uncomfortable 2 hours, the glimpse of 
the dispensary is a welcome sight. We have arranged our visit ahead 
of time, knowing that primary healthcare facilities are often closed, 
even in the morning hours. We are starting a research study about 
medicines and diagnosis for fever in this remote area of northeastern 
Tanzania. The nurse in charge is busy, and we wait outside together 
with a group of mothers and children assembled on benches and on 
the floor of the veranda. Eventually, the exhausted nurse emerges, 
and explains, ‘we are too busy; I have medicines this week, and 
the villagers know’. She says that patients often only come when 
medicines are there. Without medicines and patients they tend to 
close the dispensary and attend to their other small businesses, 
usually a shamba (back-yard farm), sometimes motorbike taxis. In 
the village, we hear similar accounts—the expectations from health 
workers is to provide medicines. If one medicine does not work, 
health workers provide another. This is what care is; medicines. A 
couple of years later, after the dispensary participated in a trial to 
reduce unnecessary antimalarial use through the provision of rapid 
diagnostic tests, we hear of the challenge of denying medicines. 
Health workers tell us that even if the test means that we cannot 
give an antimalarial, then we can give an antibiotic. This is borne out 
in subsequent quantitative analyses; a reduction in antimalarial use 
with rapid diagnostic testing leads to an increase in antibiotic use.50 51 
Here, as in many places, it is hard to imagine care without medicines. 
And often this village lacks both.
Healthcare is a means to an end here. As in many places around 
the world, life requires work; a day’s lost labour has immediate 
consequences for the whole family.52 Here, medicines enable day 
wage labourers to make it through the day at the local plantation, 
enable the shamba to be tended and give the charcoal and water 
cyclists the strength to haul their loads through the sandy tracks. 
At this local level, in a context of razor-thin margins for survival, 
antibiotic medicines enter into the balance of a price to pay for 
productivity.
issues that contribute to widespread antimicrobial use 
that often go unaddressed in conceptions of antibiotic use 
that hinge on ‘good’ and ‘bad’ individual behaviours.14 15
Drawing on long-term anthropological study, our 
research explores how antibiotics have become inter-
woven with the ways societies and economies work and 
proposes that antibiotics have become infrastructural. 
By ‘infrastructure’ we draw on the work of Bowker and 
Star,16 who conceive of infrastructures as systems that 
‘disappear almost by definition. The easier they are to 
use, the harder they are to see’ (p. 33). With antimi-
crobial resistance emerging as a major topic of global 
concern, the myriad ways that antimicrobials function as 
infrastructure are suddenly rendered visible, where previ-
ously they have been a part of the woodwork.
This is particularly palpable In LMICs, where antimicro-
bials function as a ‘quick fix’ infrastructure, put to work 
to correct the fractured infrastructures of care, water and 
sewage, hygiene and demands for ever increasing produc-
tivity. In this way, seeing antimicrobials as infrastructure 
can also ‘reveal forms of political rationality that underlie 
technological projects’17 (p. 328), demonstrating how 
neoliberal reforms, the legacies of structural adjustment 
programmes and the marginalisation of the poor and 
vulnerable have made antimicrobials an infrastructure 
that undergirds complex livelihoods in landscapes of 
scarcity, uncertainty and inequality.
This piece, then, provides a means by which to shift 
attention towards these structural dimensions related 
to AMR and antimicrobial use (AMU) that tend to 
be obscured when following an individual behaviour 
approach. We do this by focusing on the work that antibi-
otics do for the wider systems in which people are making 
their lives, as depicted in figure 1. We provide ethno-
graphic vignettes to illustrate our points, selected from 
our research in Uganda and Tanzania. We first present 
how antibiotics can be understood as a quick fix for care 
and, by extension, a quick fix for productivity. We then 
explore how antibiotics have become a quick fix for hygiene 
in some settings and more broadly a quick fix for inequality 
on local and global scales.
This research is based on long-term ethnographic 
research, including participant observation and key infor-
mant interviews, focusing on the ways that antimicrobial 
medicines are used in everyday life, and the contexts—
political, social and economic—that underscore use. 
Analysis involved collaboration of the authors with key 
stakeholders and wider research team members.
QuICk fIx for CAre And produCTIvITy
Antibiotic overuse is often described in terms of inap-
propriate ‘patient demand’ for antibiotics. The vignette 
in Box 1 can easily be read in these terms: patients 
demanding medicines to fit with their own needs. 
However, it can also be read as a struggle to provide care 
and to be productive, eased through use of antimicrobial 
medicines. Estimates of unnecessary antibiotic prescrip-
tions suggest around 50% of prescriptions and purchases 
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around the world are not needed.18 The explanation that 
this is due to demanding patients produces interventions 
that require patients to better understand the limits of 
what they can expect from healthcare providers, to stop 
pressuring them;19 and that require healthcare providers 
to employ defensive strategies as antibiotic gate-keepers.
Research has shown, however, that such interventions 
are challenging to implement and can lead to unin-
tended consequences. When healthcare providers were 
asked to limit antimalarial use through the deployment 
of rapid diagnostic tests in Uganda and Tanzania, for 
example, patients were rendered either ‘deserving’ or 
not of medicines and, by extension, of care itself.20 21 This 
outcome requires us to revisit assumptions about what 
patients are actually ‘demanding’ when they request or 
expect medicines. Is it possible that healthcare has been 
stripped down to the provision of medicines, such that to 
demand medicines is to demand care? In settings where 
access to physicians and nurses is severely constrained, 
what is care without medicines?
Multiple scholars have described a process of pharma-
ceuticalisation within biomedicine globally; a shift away 
from techniques and practices of prevention and clinical 
care to pharmaceutical intervention and treatment, such 
that primary public health and healthcare is defined in 
terms of access to pharmaceuticals.22 23 This is apparent 
in curricula for the increasing cadres of non-physician 
health workers in LMICs who are trained to enact simple 
algorithms of care that culminate in provision (or not) 
of particular medicines.24 Here we can see antimicro-
bial medicines, rather than clinical attentiveness, being 
written in to assessment and expectations of the health-
care process,25 extending to LMICs a trend previously 
documented in high income countries.26 Solidified as 
key healthcare deliverables for public sectors in LMICs 
through the ‘essential medicines’ movement in the 1970s, 
and consolidated in the subsequent neoliberal reforms 
that encouraged the opening up of the private sector to 
deliver health commodities from the 1980s onwards, anti-
microbials can be understood to have become a technical 
quick fix for care in lieu of addressing what are known to be 
wider political-economic challenges that drive ill-health, 
fragmented disease prevention efforts and fractured 
health service delivery systems.27
The vignette in Box 1 also draws our attention to 
the local economic context in which antimicrobials 
are being consumed; here we see how these medicines 
enable people’s productivity—by keeping their bodies 
productive. We also often hear of the use of antibiotics 
to improve productivity of animals and fish as growth 
promoters and to increase yields through mass treatment 
and reduced risks of infection.2 The use of antimicrobials 
in crops is also becoming better understood for fungal 
pest control and use of antibiotics for bacterial infec-
tions, for example, of oranges in Thailand.28
Across all these bodies—human, animal, fish and 
plant—we can understand antimicrobials to be enabling 
a standardised unit of productivity. For humans, the 
potential loss to productivity of reduced antimicrobial 
efficacy was a key driver in the enormous economic losses 
projected in the O’Neill29 and World Bank30 reports on 
the risks of AMR. For animals, the use of antimicrobials 
enables standard sized animals, fish and standard-looking 
fruit to be generated and traded in global economic 
circuits. This clear link between antimicrobials and econ-
omies exposes the way that antimicrobials have become 
integrated with our systems—a quick fix for productivity—
that enables the standardisation and predictability of 
labour that are required in global economic systems.
QuICk fIx for HygIene And IneQuAlITy
Individuals, carers and health workers in the Global 
South often find themselves using and prescribing anti-
biotics because of infections caught due to unsanitary 
conditions in healthcare settings and at home, as well 
as in anticipation of such infections.31 32 The reasons for 
such prophylactic antimicrobial prescribing are known 
to be complex33 34 but in part can be understood as an 
extension of infection prevention and control measures. 
This prophylactic use is necessary, many explain, because 
of inadequate sterilisation of patient rooms and medical 
tools in hospitals, lack of hospital beds and overcrowding 
and the unhygienic living and working conditions of 
patients themselves.
Our ongoing research in Uganda and Thailand under-
scores that antibiotic use is often a response to patients’ 
lack of access to clean water and sanitary toileting due 
to inadequate infrastructural provision in informal settle-
ments and/or work under precarious and unhygienic 
conditions, as street vendors, household cleaners or 
labourers in industrial factories. Under these conditions, 
we observe that antibiotics function as a quick fix for lack of 
hygiene, acting as substitutes for the non-hygienic condi-
tions that health workers and individuals work and live 
within.
Research to date has demonstrated how good hygiene 
practices in hospitals, clinics and everyday life can prevent 
infection,35 36 but the methods and/or interventions 
aimed at attaining those good sanitary conditions have 
often been scaled at the level of the individual, focused 
on changing individual hygiene behaviours. For example, 
many initiatives focus on hand washing and hygiene 
knowledge and awareness campaigns for health workers 
and the public.15 37 38 Achieving behavioural changes like 
hand hygiene, however, is not straightforward,39 40 often 
failing due to a lack of resources, fractured infrastruc-
tures and competing priorities.41 42
The saddling of responsibility for hygiene with individ-
uals who have limited ability to change the environment 
in which ‘good hygiene behaviour’ is expected to operate 
leaves these individuals to find solutions that are more 
feasible and within their control, such as the use of anti-
biotics. As the vignette in Box 2 demonstrates, hygiene is 
rarely an individual issue. A lack of hygiene can also be 
understood as emerging from the inequitable distribution 
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box 2 Antibiotics as a Quick fix for Hygiene and 
Inequality
Grace brings us into her house to show us her plastic basket of 
medicines she keeps on hand at home. It is a small collection of 
Panadol (paracetamol), some amoxicillin tablets and a full box of 
metronidazole. She explains that the metronidazole is an absolute 
necessity here in this urban informal settlement in downtown 
Kampala, Uganda, where chronic diarrhoea—and the serious 
abdominal pain associated with it—is a condition that many adults 
and children live with every day. Walking through the settlement with 
her we pass the few existing fee-for-use latrines in the community, 
but Grace explains that most cannot afford them, and that regardless, 
many avoid them because they are so unclean. She explains that 
many people—including her—simply use home bucket systems or 
polythene bags for toileting, and then dispose of their waste either 
in the open drainage channels that run through the settlement or 
in community rubbish piles. These are the same drainage channels 
where people must wash their clothes and collect water for their 
livestock and gardens. Further exacerbating this situation, the 
settlement is built on and beside a wetland area, and these drainage 
channels often flash flood during the rainy season, with waters rising 
to knee-height and circulating inside people’s homes, their livestock 
pens and their small gardens. Here, antibiotics are put to use to make 
unavoidable diarrhoeal disease bearable, enabling people to carry on 
with their work and family commitments despite chronic diarrhoea 
and abdominal pain. There is little political will to tackle these issues, 
as the local press describes the informal settlement as a problematic 
‘slum’, while the people who live there are cast as ‘illegal squatters’ 
and criminals. Here, antibiotics provide a quick fix for wider structural 
and political issues, manifested as lack of hygiene in contexts of 
poverty.
of what is required to be hygienic. In the Global South, 
when we think about inadequacies in hygiene systems, 
we must consider its relationship to structural violence, 
along with the marginalisation and criminalisation of the 
poor.43
This entails a historical consideration of how colo-
nial ideas about the ‘backwardness’ and ‘uncivilised’ 
behaviours of colonised peoples continues to shape global 
health policy and interventions today.44 45 For example, 
when clean water is not made available to certain popula-
tions,46 when public hospitals are underfunded and left 
to decline and make do without necessary products and 
materials,47 or when affordable housing is inaccessible, 
and people’s solutions to housing crises—like informal 
settlements—are deemed ‘illegal’ and ‘disordered’,48 
access to sanitary infrastructure is made unequal. This is 
not about individual behaviour, but is often imagined as 
such.
As the vignette from Box 2 depicts, when antibiotics are 
deployed as a quick fix for hygiene inadequacies, they are 
being used as a technical fix in these constrained settings 
beset by inequality, where other options are made limited 
or unavailable. When hygiene is approached as a tech-
nical gap or a behaviour change issue, we risk actively 
obscuring inequality. This analysis suggests that antibiotic 
use as a quick fix for hygiene cannot easily be disentangled 
from the use of antibiotics as a quick fix for inequality.
The lure of antibiotics as a magic bullet to fix these 
systemic challenges is strong and made evident in the 
promise of recent trials that have indicated the poten-
tial for the mass distribution of antibiotics to preschool 
children to lower mortality rates in countries that are far 
from reaching the goal posts of the sustainable develop-
ment goals (SDGs).49 Here, we can understand antibi-
otics as a quick fix for the entrenched inequalities that 
have made reaching the SDGs so tricky in the first place. 
By cutting through these barriers, the prophylactic use 
of broad-spectrum antibiotics depoliticises the unequal 
causes of morbidity and mortality, enabling political 
achievements at a far lower cost than would be required 
to change the conditions that necessitated the SDGs in 
the first place.
ConCluSIon
This paper uses the concept of the quick fix as a way to 
recognise the limits of our vision on solutions to AMR. 
By attending to antibiotics as a quick fix, we show how 
these substances can usefully be understood as a kind 
of gap-filling infrastructure that performs certain kinds 
of work in our societies—often replacing people, atten-
tiveness, political change, recuperation and technical 
infrastructures. Antibiotics are deployed to paper over 
long-term structural issues that undermine care provi-
sion, drive increased productivity and correct for hygiene 
issues caused by entrenched inequality. We attend to anti-
biotics here as having themselves become a kind of infra-
structure that enables modern life.
This approach shifts the conversation away from the 
more commonplace binary of ‘appropriate/inappro-
priate’ antibiotic use. Instead we can ask how else we 
might take seriously and care for people defined beyond 
bodies and pathogens? How else might we imagine our 
systems of healthcare, infrastructure and political-econ-
omies, such that we can take seriously and care for our 
populations beyond units of productivity? The impor-
tance of this type of analysis lies in its ability to render 
visible the reasons that antimicrobial use is so entrenched 
in our societies.
As we develop new modes of thinking about antibi-
otic use, it will inevitably be tempting to try to replace 
one quick-fix for another, or to dismiss critical anal-
yses as possibly impractical or too costly. This need not 
be the case. Recognising many of our AMR solutions 
as quick fixes allows us to raise our line of sight into the 
longer term, generating more systemic solutions that 
have greater chance of achieving equitable impact. This 
will necessarily involve rethinking assumptions about 
so-called individual behaviours and allow us to consider 
how structural solutions, which provide the scaffolding 
for more equitable health and care, can be developed, 
funded and implemented. How we understand the issue 
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of antimicrobial use matters if we want to successfully deal 
with the consequences of AMR for modern medicine.
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